A detailed history of Daiwa Securities Group Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 70,191 shares of MRNA stock, worth $2.79 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
70,191
Previous 59,231 18.5%
Holding current value
$2.79 Million
Previous $7.03 Million 33.31%
% of portfolio
0.02%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$63.64 - $125.14 $697,494 - $1.37 Million
10,960 Added 18.5%
70,191 $4.69 Million
Q2 2024

Aug 07, 2024

BUY
$101.21 - $166.61 $537,323 - $884,532
5,309 Added 9.85%
59,231 $7.03 Million
Q1 2024

May 02, 2024

BUY
$85.37 - $115.44 $428,728 - $579,739
5,022 Added 10.27%
53,922 $5.75 Million
Q4 2023

Jan 31, 2024

BUY
$69.51 - $104.43 $172,106 - $258,568
2,476 Added 5.33%
48,900 $4.86 Million
Q3 2023

Nov 01, 2023

BUY
$96.41 - $126.61 $570,265 - $748,898
5,915 Added 14.6%
46,424 $4.8 Million
Q2 2023

Jul 31, 2023

SELL
$118.5 - $160.53 $63,279 - $85,723
-534 Reduced 1.3%
40,509 $4.92 Million
Q1 2023

May 02, 2023

BUY
$135.66 - $197.02 $223,160 - $324,097
1,645 Added 4.18%
41,043 $6.3 Million
Q4 2022

Feb 06, 2023

BUY
$118.38 - $210.04 $84,404 - $149,758
713 Added 1.84%
39,398 $7.08 Million
Q3 2022

Nov 02, 2022

BUY
$118.07 - $194.18 $164,117 - $269,910
1,390 Added 3.73%
38,685 $4.58 Million
Q2 2022

Aug 09, 2022

BUY
$117.13 - $176.59 $162,927 - $245,636
1,391 Added 3.87%
37,295 $5.33 Million
Q1 2022

Apr 29, 2022

BUY
$126.46 - $235.05 $421,870 - $784,126
3,336 Added 10.24%
35,904 $6.19 Million
Q4 2021

Feb 03, 2022

BUY
$225.82 - $368.51 $580,131 - $946,702
2,569 Added 8.56%
32,568 $8.27 Million
Q3 2021

Nov 05, 2021

BUY
$221.9 - $484.47 $1.5 Million - $3.27 Million
6,740 Added 28.98%
29,999 $11.5 Million
Q2 2021

Aug 06, 2021

BUY
$129.91 - $234.98 $249,946 - $452,101
1,924 Added 9.02%
23,259 $5.47 Million
Q1 2021

May 03, 2021

BUY
$109.18 - $185.98 $313,674 - $534,320
2,873 Added 15.56%
21,335 $2.79 Million
Q4 2020

Feb 04, 2021

SELL
$65.74 - $169.86 $24,849 - $64,207
-378 Reduced 2.01%
18,462 $1.93 Million
Q3 2020

Nov 02, 2020

BUY
$54.34 - $94.85 $921,878 - $1.61 Million
16,965 Added 904.8%
18,840 $1.33 Million
Q1 2020

May 14, 2020

SELL
$17.78 - $31.58 $106 - $189
-6 Reduced 0.32%
1,875 $56,000
Q4 2019

Jan 31, 2020

BUY
$13.93 - $21.28 $26,202 - $40,027
1,881 New
1,881 $37,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.